TLR3 and cancer: We believe that the findings presented here broaden our understandings of the roles of TLR3, β-catenin and NF-κB in CSC biology, and also have potential clinical implications in terms of preventing induction of CSC phenotypes and targeting cancer stem-like cells under inflammatory conditions and endogenous stimuli of damaged cellular components.